Neurologic complications after chlorhexidine antisepsis for spinal anesthesia
Hans P Sviggum1, Adam K Jacob, Katherine W Arendt
1Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA.
Background And Objectives:
Recent reports of infectious complications after neuraxial procedures highlight the importance of scrupulous aseptic technique. Although chlorhexidine gluconate (CHG) has several advantages over other antiseptic agents; including a more rapid onset of action, an extended duration of effect, and rare bacterial resistance, it is not approved by the US Food and Drug Administration for use before lumbar puncture because of absence of clinical safety evidence. The objective of this retrospective cohort study was to test the hypothesis that the incidence of neurologic complications associated with spinal anesthesia after CHG skin antisepsis is not different than the known incidence of neurologic complications associated with spinal anesthesia.
Methods:
All patients 18 years or older who underwent spinal anesthesia at Mayo Clinic Rochester from 2006 to 2010 were identified. The primary outcome variable was the presence of any new or progressive neurologic deficit documented within 7 days of spinal anesthesia. The etiology of a patient's neurologic complication was independently categorized as possibly or unlikely related to the spinal anesthetic by 3 investigators. Consensus among all reviewers was required for final category assignment.
Results:
A total of 11,095 patients received 12,465 spinal anesthetics during the study period. Overall, 57 cases (0.46%; 95% confidence interval, 0.34%-0.58%) met criteria for neurologic complication. Spinal anesthesia was felt to be the possible etiology of 5 neurologic complications (0.04%; 95% confidence interval, 0.00%-0.08%); all completely resolved within 30 days.
Discussion:
The incidence of neurologic complications possibly associated with spinal anesthesia (0.04%) after CHG skin antisepsis is consistent with previous reports of neurologic complications after spinal anesthesia. These results support the hypothesis that CHG can be used for skin antisepsis before spinal placement without increasing the risk of neurologic complications attributed to the spinal anesthetic.
Insights
Chlorhexidine gluconate (CHG) skin antisepsis before spinal anesthesia did not increase neurologic complication rates. This study supports CHG use for lumbar puncture, showing safety comparable to existing methods.
Area of Science:
- Anesthesiology
- Infectious Disease Prevention
- Neurosurgery
Background:
- Neuraxial procedures require strict aseptic technique to prevent infectious complications.
- Chlorhexidine gluconate (CHG) offers advantages over other antiseptics but lacks FDA approval for lumbar puncture due to limited clinical safety data.
- This study addresses the safety of CHG for spinal anesthesia antisepsis.
Purpose of the Study:
- To evaluate if chlorhexidine gluconate (CHG) skin antisepsis before spinal anesthesia is associated with a different incidence of neurologic complications compared to historical data.
- To test the hypothesis that CHG use does not increase the risk of neurologic complications after spinal anesthesia.
Main Methods:
- A retrospective cohort study analyzed patients aged 18+ undergoing spinal anesthesia between 2006-2010.
- The primary outcome was new or progressive neurologic deficit within 7 days of anesthesia.
- Neurologic complication etiology was independently assessed by three investigators, requiring consensus for classification.
Main Results:
- 11,095 patients received 12,465 spinal anesthetics; 57 cases (0.46%) had neurologic complications.
- Spinal anesthesia was implicated in 5 cases (0.04%), all resolving within 30 days.
- The incidence of neurologic complications was consistent with previous reports.
Conclusions:
- The incidence of neurologic complications possibly linked to spinal anesthesia after CHG antisepsis (0.04%) aligns with existing literature.
- Findings support the use of CHG for skin antisepsis prior to spinal anesthesia, indicating no increased risk of anesthetic-related neurologic complications.
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
